Carbylan Therapeutics' Series A Round

Carbylan Therapeutics raised a round of funding on January 10, 2006.

Carbylan Therapeutics is a clinical-stage, specialty, pharmaceutical company focused on the development and commercialization of proprietary combination therapies that address significant unmet medica…

Articles about Carbylan Therapeutics' Series A Round: